Phase
Condition
Hormone Deficiencies
Stress
Weight Loss
Treatment
Combined aerobic + strength training
Combined strength + HIIT training
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosed with MASLD by ultrasound, CAP and/or biopsy
Age between 18 and 75 years old
No significant liver fibrosis (Fibroscan < 7.5 kPa; if it is between >7.5 and <10,there must be absence of liver fibrosis in the biopsy)
Exclusion
Exclusion Criteria:
Presence of other liver diseases that may contribute to the clinical presentation inthe patient
Severe cardiovascular, orthopedic, physical or other illnesses that make itimpossible to participate in the study's exercise rehabilitation program or wheresafety cannot be guaranteed
Pregnancy
Pharmacological treatment that directly affects MASLD (e.g. GLP-1 analogues)
A change in medication in the last three months before the study that affectsmetabolic disease stability
Study Design
Study Description
Connect with a study center
Ghent University Hospital
Ghent, 9000
BelgiumActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.